Disclosures for "Designing Transgene Vectors for ALS Therapeutics "
-
Dr. Wilkins has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilkins has received intellectual property interests from a discovery or technology relating to health care.
-
Ms. Pisliakova has nothing to disclose.
-
Prof. Ule has nothing to disclose.
-
Prof. Fratta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TRV. Prof. Fratta has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for VectorY. The institution of Prof. Fratta has received research support from MRC. The institution of Prof. Fratta has received research support from NIH. The institution of Prof. Fratta has received research support from TRV.